Introduction: The availability of peptide drugs is still limited
All or most all of the FDA approved and commercially available drugs are targeting proteins. In the natural environment, these proteins can be stimulated by small molecules, peptides, and other proteins. However, while the field of small molecules has been researched extensively in the past, newer molecule classes are slowly evolving and becoming commercially accessible.
Proteins are large macromolecules made up of peptide chains. They often have a very characteristic tertiary structure, which offers specific recognizable docking sides for other molecules. One of the central